The Japanese pharmaceutical company Takeda has officially commissioned a new photovoltaic system at its production site in Oranienburg, near Berlin. After seven months of construction, the system was inaugurated during a ceremony. With an investment of approximately €4 million from its own funds, Takeda is underscoring its long-term commitment to the Oranienburg site and to sustainable industrial value creation in Germany.
“The photovoltaic system at the Oranienburg site generates approximately 1,500 megawatt-hours of electricity annually and saves about 650 tons of CO₂. That corresponds to the annual consumption of around 350 single-family homes. In this way, we are making a measurable contribution to reducing our ecological footprint right here on site,” explained Chris Buttkus, Head of the Oranienburg site and member of Takeda’s management team in Germany. “For us, it is crucial that we make our production responsible, resilient, and sustainable in the long term. Investments in a sustainable energy supply are a key component in permanently strengthening the Oranienburg site.”
By consistently using the electricity it generates on-site, Takeda is also contributing to sustainable and local energy use. With the solar power system, Takeda is strengthening the site’s self-sufficient energy supply and reducing its reliance on the public power grid.
“For us as an energy-intensive production site, taking responsibility for our own electricity needs sends an important signal,” said Buttkus. “Our photovoltaic system is not an isolated sustainability project, but part of a forward-looking site strategy in the interest of the company, the workforce, and the local community.”
The investment underscores the importance of reliable framework conditions for sustainable industrial development and the ongoing transition toward competitive value creation—driven by investments in technology, infrastructure, and employees. A sustainable energy supply is a key component of competitive production sites and strengthens innovation, security of supply, and value creation in Germany.
CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.
DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.
Novo Nordisk announced a global workforce reduction of approximately 9,000 positions to streamline operations and reinvest DKK 8 billion (€1 billion) in growth opportunities for diabetes and obesity treatments.
BASF sells a majority stake in its coatings business to the investor Carlyle.
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.
Jens Birgersson becomes new Brenntag CEO
Carbon black manufacturer Orion Engineered Carbons plans to rationalize production lines in North and South America and EMEA.
News, trends and background information as well as the latest issue of CHEManager International
By registering you agree to our data protection guidelines.
Many thanks for you registration!
